Stockysis — AI-Powered Stock News & Sentiment Analysis

B. Riley Securities Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18

Benzinga Newsdesk www.benzinga.com Neutral 52.9%

Neg 0% Neu 52.9% Pos 0%

B. Riley Securities analyst Neil Chatterji maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and lowers the price target from $28 to $18.

Comments

No comments yet. Be the first!